The use of transformed T cell lines for clonal expansion of human B cells from peripheral blood, spleen, and tumor-infiltrating lymphocytes.

Human transformed T cell lines were able to induce polyclonal B cell activation and immunoglobulin (Ig) secretion from peripheral blood mononuclear cells, spleen cells and tumor-infiltrating lymphocytes (TIL). Cells from one of the lines tested, MOT, did not require any exogenous stimuli to induce maximal responses and under similar conditions induced higher levels of response than peripheral blood T cells or other T cell lines. MOT-induced B cell activation and Ig secretion required cell contact and factors present in the MOT culture supernatant. MOT cells induced B cell responses from TIL in the three tumors tested (melanoma, ovarian and colon cancer) and HIV-specific immunoglobulin secretion by spleen cells from an HIV+ patient.

[1]  S. Nakamura,et al.  Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. , 1992, Science.

[2]  P. Lipsky,et al.  Frequency of human B cells that differentiate in response to anti-CD3-activated T cells. , 1990, Journal of immunology.

[3]  L. Wold,et al.  Lymphokine-activated killer (LAK) cell activity in tumor-infiltrating lymphocytes from non-small cell lung cancer. , 1989, American journal of clinical pathology.

[4]  S. Nakamura,et al.  Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. , 1988, Science.

[5]  P. Lipsky,et al.  T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. , 1988, Journal of immunology.

[6]  H. Marquardt,et al.  Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. , 1987, Journal of immunology.

[7]  A. Fauci,et al.  Immunologic abnormalities in the acquired immunodeficiency syndrome. , 1986, Progress in allergy.

[8]  S. Miescher,et al.  Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. , 1986, Journal of immunological methods.

[9]  P. Lipsky,et al.  The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. , 1986, Journal of immunology.

[10]  G. Klein,et al.  Epstein-Barr virus susceptibility of normal human B lymphocyte populations , 1984, The Journal of experimental medicine.

[11]  P. Lipsky,et al.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. , 1983, Journal of immunology.

[12]  S. Quan,et al.  Human T-cell leukemia virus type II transforms normal human lymphocytes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Sikora,et al.  Human hybridomas from patients with malignant disease. , 1983, British Journal of Cancer.

[14]  M. Robert-Guroff,et al.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. , 1982, Science.

[15]  Masakatsu Imamura,et al.  Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: An immunoperoxidase study with anti‐human t‐ and b‐cell sera , 1982 .

[16]  A. Saxon,et al.  T-lymphocyte variant of hairy-cell leukemia. , 1978, Annals of internal medicine.

[17]  A. Saxon,et al.  Single step separation of human T and B cells using AET treated srbc rosettes. , 1976, Journal of immunological methods.

[18]  E. Hersh,et al.  Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient. , 1976, The Medical clinics of North America.

[19]  M. Moore,et al.  Human tumor-infiltrating lymphocytes: a marker of host response. , 1985, Seminars in hematology.

[20]  N. Bersch,et al.  Production of erythroid-potentiating activity by a human T-lymphoblast cell line. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Robinson,et al.  Efficiency of transformation of lymphocytes by Epstein-Barr virus. , 1977, Virology.